Literature DB >> 15080540

Treatment of East Coast fever of cattle with a combination of parvaquone and frusemide.

R Azuba Musoke1, R Tweyongyere, E Bizimenyera, C Waiswa, A Mugisha, S Biryomumaisho, N McHardy.   

Abstract

Pulmonary oedema is a common sign of East Coast fever (ECF, Theileria parva infection) of cattle. A trial was conducted on farms in Uganda to compare a product containing both the antitheilerial compound parvaquone and the diuretic compound frusemide with one containing only parvaquone, in the treatment of ECF. The trial involved 40 clinical cases of ECF, some of them complicated by other infections, in cattle of all ages and on several farms. Confirmed cases were treated with either parvaquone+frusemide (P+F) or parvaquone alone (P). Survival after treatment with P+F was 77% compared with 71% with P. Five of the 10 fatalities were complicated cases. The cure rate for severe but uncomplicated ECF was 89% with P+F and 40% with P. Pulmonary signs were resolved within 24-48 h after treatment with P+F and clinical recovery was noticeably more rapid than with P. The antiparasitic effect of the two treatments was similar. P+F could be particularly useful when reporting, diagnosis or laboratory confirmation of ECF is delayed, because advanced cases are more likely to be encountered under these circumstances.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080540     DOI: 10.1023/b:trop.0000016832.69136.68

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  11 in total

1.  Field evaluation of parvaquone against naturally occurring East Coast fever.

Authors:  H A Mbwambo; P A Mkonyi; R B Chua
Journal:  Vet Parasitol       Date:  1987-02       Impact factor: 2.738

2.  Treatment of East Coast fever: a comparison of parvaquone and buparvaquone.

Authors:  G R Muraguri; H K Kiara; N McHardy
Journal:  Vet Parasitol       Date:  1999-11       Impact factor: 2.738

3.  The use of tetracyclines on the chemotherapy of experimental East Coast Fever (theileria parva infection of cattle).

Authors:  C G Brown; D E Radley; M J Burridge; M P Cunningham
Journal:  Tropenmed Parasitol       Date:  1977-12

4.  Clinical trial of parvaquone for the treatment of East Coast fever in Kenya.

Authors:  S Chema; S Waghela; A D James; T T Dolan; A S Young; W N Masiga; A D Irvin; G H Mulela; L S Wekesa
Journal:  Vet Rec       Date:  1986-05-24       Impact factor: 2.695

5.  The effect of East Coast fever immunisation and different acaricidal treatments on the productivity of beef cattle.

Authors:  S P Morzaria; A D Irvin; J Wathanga; D D'Souza; J Katende; A S Young; J Scott; G Gettinby
Journal:  Vet Rec       Date:  1988-09-17       Impact factor: 2.695

Review 6.  Clinical and diagnostic features of East Coast fever (Theileria parva) infection of cattle.

Authors:  A D Irvin; D M Mwamachi
Journal:  Vet Rec       Date:  1983-08-27       Impact factor: 2.695

7.  Chemotherapy of East Coast fever: parvaquone treatment of clinical disease induced by isolates of Theileria parva.

Authors:  T T Dolan; A S Young; B L Leitch; D A Stagg
Journal:  Vet Parasitol       Date:  1984-08       Impact factor: 2.738

8.  Activity of 10 naphthoquinones, including parvaquone (993C) and menoctone, in cattle artificially infected with Theileria parva.

Authors:  N McHardy; A T Hudson; D W Morgan; D G Rae; T T Dolan
Journal:  Res Vet Sci       Date:  1983-11       Impact factor: 2.534

9.  Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone.

Authors:  N McHardy; L S Wekesa; A T Hudson; A W Randall
Journal:  Res Vet Sci       Date:  1985-07       Impact factor: 2.534

10.  Chemotherapy of field cases of East Coast fever using halofuginone lactate.

Authors:  H A Mbwambo; P A Mkonyi; J Sondi; K A Lekaki
Journal:  Acta Trop       Date:  1986-12       Impact factor: 3.112

View more
  1 in total

Review 1.  A review on prevalence, control measure, and tolerance of Tanzania Shorthorn Zebu cattle to East Coast fever in Tanzania.

Authors:  E L K Laisser; S W Chenyambuga; E D Karimuribo; G Msalya; M J Kipanyula; A J Mwilawa; R H Mdegela; L J M Kusiluka
Journal:  Trop Anim Health Prod       Date:  2017-03-22       Impact factor: 1.559

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.